Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2002
08/27/2002CA2098307C Determination of tricyclic antidepressant drugs in the presence of interfering substances
08/23/2002CA2372608A1 Reactant and process for identifying and counting biological cells
08/23/2002CA2370213A1 Assays for assessing a.beta.-tau aggregation
08/22/2002WO2002065138A1 Microchip
08/22/2002WO2002065137A2 Diagnosis of atherosclerosis
08/22/2002WO2002065136A2 Yeast screens for agents affecting protein folding
08/22/2002WO2002065135A2 Determination of level of immunoglobulin modification
08/22/2002WO2002065134A2 Modulators of p53-p300 interactions and screening methods therefor
08/22/2002WO2002065133A2 Ligands used for detecting prions
08/22/2002WO2002065132A2 Detectable compositions, methods of forming the same and detection techniques
08/22/2002WO2002065131A1 Method of detecting bacterium belonging to the genus vibrio, detection reagent and antibody to be used therein
08/22/2002WO2002065130A1 Diagnostic method for bacterial vaginosis based on detecting antibodies against gvh toxin of gardnerella vaginalis
08/22/2002WO2002065129A2 Epitopic sequences for diagnosing infection by chlamydia trachomatis
08/22/2002WO2002065128A2 Urine assay for ovarian reserve
08/22/2002WO2002065127A2 A system and method for characterizing the permittivity of molecular events
08/22/2002WO2002065126A2 Use of troponin i as a species marker protein for meat speciation in both raw and heat-processed products
08/22/2002WO2002065124A2 Improved method for detecting cells
08/22/2002WO2002065123A2 Biochemical method and apparatus for detecting protein characteristics
08/22/2002WO2002065122A1 Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples
08/22/2002WO2002065120A1 Multi-drug titration and evaluation
08/22/2002WO2002065119A1 A method for the prediction of molecular interaction networks
08/22/2002WO2002065118A1 Specimen-linked database
08/22/2002WO2002065117A1 Method of selecting wood for mechanical pulping
08/22/2002WO2002065116A1 Method of screening drug controlling interaction between arf protein and a10 protein
08/22/2002WO2002065115A2 Device and method for detecting the presence of an analyte
08/22/2002WO2002065112A1 Apparatus for detecting interaction between biopolymer and ligand and method thereof
08/22/2002WO2002065098A1 Liquid densimeter
08/22/2002WO2002065094A2 Bottom plate for lysimeters and method for closing lysimeters with a bottom plate
08/22/2002WO2002065092A2 Devices and methods for high throughput patch clamp assays
08/22/2002WO2002065091A2 Pin1 as marker for abnormal cell growth
08/22/2002WO2002065087A2 Biological fluid analysis device
08/22/2002WO2002065086A2 Method and device for measuring the efficacy of a lubricating oil and uses thereof
08/22/2002WO2002065063A1 Device for determining the mass of a flowing, foaming flow of liquid
08/22/2002WO2002064840A2 Methods for identifying compounds that inhibit or reduce ptp1b expression
08/22/2002WO2002064837A1 Radiative decay engineering
08/22/2002WO2002064834A1 Novel two-hybrid system and use thereof
08/22/2002WO2002064832A1 Method of examining allergic disease
08/22/2002WO2002064830A2 Method for detecting dna polymerisation
08/22/2002WO2002064829A2 Biochemical method and apparatus for detecting genetic characteristics
08/22/2002WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
08/22/2002WO2002064825A2 Microelectronic array devices to perform multiplex immunoassay analysis
08/22/2002WO2002064824A2 Oligonucleotide probes used to detect parodontopathogenic bacteria by in situ hybridization
08/22/2002WO2002064823A2 Method for detecting and/or quantifying an analyte
08/22/2002WO2002064820A1 Dna markers for meat tenderness
08/22/2002WO2002064819A1 Novel assay method
08/22/2002WO2002064816A2 Multiple determinants for metabolic phenotypes
08/22/2002WO2002064815A2 33945, a human glycosyltransferase family member and uses therefor
08/22/2002WO2002064811A2 Method for producing recombinant proteins marked with at least one isotope
08/22/2002WO2002064797A2 Mitochondrial topoisomerase i
08/22/2002WO2002064795A2 Putative human enzymes
08/22/2002WO2002064794A2 Herbicide target genes and methods
08/22/2002WO2002064792A2 Molecules for disease detection and treatment
08/22/2002WO2002064791A2 Proteins and nucleic acids encoding same
08/22/2002WO2002064790A2 Jfy1 protein induces rapid apoptosis
08/22/2002WO2002064788A2 Compositions and methods relating to lung specific genes and proteins
08/22/2002WO2002064787A1 Neurotonin and use thereof
08/22/2002WO2002064785A1 NOVEL CLOCK GENE Bmal2
08/22/2002WO2002064784A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
08/22/2002WO2002064781A2 Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity
08/22/2002WO2002064771A1 Novel cell adhesion molecule specific to activated leukocyte
08/22/2002WO2002064770A1 Novel scavenger receptor class a protein
08/22/2002WO2002064763A1 Novel human poly(a)polymerase gamma (pap gamma)
08/22/2002WO2002064758A1 An optical method for testing sensitivity of cells
08/22/2002WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002WO2002064747A2 Fusion proteins based upon somatostatin receptors
08/22/2002WO2002064734A2 Identification of target-specific folding sites in peptides and proteins
08/22/2002WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/22/2002WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89)
08/22/2002WO2002064633A1 Monoclonal antibody against an unknown antigen from amniotic flu id and its method of preparation
08/22/2002WO2002064631A2 T1r taste receptors and genes encoding same
08/22/2002WO2002064629A2 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
08/22/2002WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
08/22/2002WO2002064625A1 Matrix gene expression in chondrogenesis
08/22/2002WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
08/22/2002WO2002064618A2 Methods of identifying agents that mediate polypeptide aggregation
08/22/2002WO2002064615A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof
08/22/2002WO2002064556A2 Complex carbohydrate arrays and methods for the manufacture and uses thereof
08/22/2002WO2002064169A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
08/22/2002WO2002064165A1 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
08/22/2002WO2002064164A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same
08/22/2002WO2002064161A2 Method and compositions for immunization with the pseudomonas v antigen
08/22/2002WO2002064159A1 Remedies for tumor in hematopoietic organs
08/22/2002WO2002064139A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
08/22/2002WO2002064097A2 Vegf-d expression in brain cancer
08/22/2002WO2002064092A2 Method for evaluating therapeutic efficacy
08/22/2002WO2002064038A2 System for evaluating data obtained in a biochip measurement device
08/22/2002WO2002064026A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno
08/22/2002WO2002064023A2 Fra-1 expression in brain cancer
08/22/2002WO2002064022A2 Therapy for cerebral vasospasm
08/22/2002WO2002064018A2 Immortalized human familial prostatic cancer cell lines
08/22/2002WO2002064015A2 Pin1 as a marker for prostate cancer
08/22/2002WO2002063939A2 Method and system for fecal and ingesta detection during meat and poultry processing
08/22/2002WO2002050539A3 Solid phase substrates for structured reaction substrates
08/22/2002WO2002050508A3 Coating for gas sensors
08/22/2002WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer
08/22/2002WO2002044361A3 Eukaryotic expression libraries based on double lox recombination and methods of use
08/22/2002WO2002043559A3 Methods and kits for diagnosis of schizophrenia
08/22/2002WO2002040698A3 Analysis of soluble factor biological markers
08/22/2002WO2002035308A3 Method and device for optically determining bulk density and uniformity of web configured material during in-line processing
08/22/2002WO2002032404A3 Nanoparticles
1 ... 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 ... 3937